FinHisaab LogoFinHisaab

Command Palette

Search for a command to run...

LCI · Lucky Core Industries Limited

Corporate Briefing Session - Presentation

Filed
2 October 2026 at 12:36 pm
Category
Briefings
Sentiment
Neutral
Impact
High

AI executive summary

Lucky Core Industries Limited (LCI) released its FY2025-26 investor briefing presentation, reporting an unconsolidated and consolidated profit after tax (PAT) of PKR 9.7 billion, down 17% year-on-year, alongside a dividend per share (DPS) of PKR 10.50.

Key takeaways

  • Unconsolidated revenue stood at PKR 113.2 billion, representing a 6% decrease compared to SPLY.
  • Unconsolidated EBIT declined 18% year-on-year to PKR 14.7 billion.
  • Unconsolidated PAT came in at PKR 9.7 billion, down 17% year-on-year, with an EPS of PKR 20.99.
  • Consolidated revenue reached PKR 113.4 billion, reflecting a 5% decrease year-on-year.
  • Consolidated EBIT was recorded at PKR 14.7 billion, down 18% year-on-year, with a consolidated PAT of PKR 9.7 billion and consolidated EPS of PKR 21.11.
  • The company declared a dividend per share (DPS) of PKR 10.50, representing a 50% payout ratio.
  • Soda Ash business net turnover decreased by 9% year-on-year to PKR 36,213 million, with EBIT dropping 33% to PKR 5,668 million and production volume declining 8% to 426k tonnes.
  • Soda Ash domestic volumes increased mainly due to higher sales, whereas export sales fell 59% year-on-year due to tough international competition.
  • Polyester business net turnover dropped 13% year-on-year to PKR 34,478 million, with EBIT plunging 74% to PKR 479 million and production volume declining 3% to 97k tonnes.
  • Polyester segment faced pressure from subdued local demand and higher imports of PSF, supported partly by a continued focus on specialized variants.
  • Pharmaceuticals business net turnover rose 5% year-on-year to PKR 22,198 million, with EBIT increasing 16% to PKR 5,350 million, supported by six flagship brands exceeding PKR 1 billion in sales value and the full-year impact of Pfizer asset acquisitions concluded in September 2024.
  • Animal Health business net turnover grew 17% year-on-year to PKR 7,191 million and EBIT increased 20% to PKR 1,298 million, driven by volume growth across both poultry and livestock segments.
  • Chemicals and Agri-Sciences business net turnover decreased 1% year-on-year to PKR 13,175 million and EBIT fell 5% to PKR 1,910 million, impacted by disrupted crop cycles and historically low pest pressure weighing on agri demand.
  • For FY2026-27 Q1 outlook, overall domestic demand is expected to remain subdued amid geopolitical volatility and an uncertain macroeconomic environment.
  • Low-priced imports are expected to continue putting pressure on the Soda Ash and Polyester businesses in FY2026-27 Q1.
  • LCI plans to continue focusing on strengthening its Pharmaceuticals and Animal Health businesses through brand building, distribution expansion, and deeper farmer reach in FY2026-27 Q1.
  • #financial-results
  • #fy2026
  • #earnings
  • #dividend
  • #corporate-briefing

This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.